Can-Fite BioPharma Ltd. Shares Authorized
Can-Fite BioPharma Ltd. (CANF) had Shares Authorized of 14.00 million shares as of 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Balance Sheet › Equity › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesAuthorized · last filed 2026-03-26
- 2025-12-31: Common Stock, Shares Authorized 14.00M shares.
- 2025-06-30: Common Stock, Shares Authorized 6.67M shares; Common Stock, Shares Authorized as first filed 20.00B shares.
- 2024-12-31: Common Stock, Shares Authorized 3.33M shares; Common Stock, Shares Authorized as first filed 10.00B shares.
- 2024-07-03: Common Stock, Shares Authorized 3.33M shares.
| Period end | Common Stock, Shares Authorized | Common Stock, Shares Authorized as first filed |
|---|---|---|
| 2025-12-31 | 14.00M shares 20-F · filed 2026-03-26 | |
| 2025-06-30 | 6.67M shares 20-F · filed 2026-03-26 | 20.00B shares 6-K · filed 2025-08-28 |
| 2024-12-31 | 3.33M shares 20-F · filed 2026-03-26 | 10.00B shares 20-F · filed 2025-04-14 |
| 2024-07-03 | 3.33M shares 20-F · filed 2026-03-26 | |
| 2024-06-30 | 5.00B shares 6-K · filed 2024-08-29 | |
| 2023-12-31 | 5.00B shares 20-F · filed 2025-04-14 | |
| 2023-06-30 | 5.00B shares 6-K · filed 2023-08-31 | |
| 2022-12-31 | 5.00B shares 20-F · filed 2024-03-28 | |
| 2022-06-30 | 5.00B shares 6-K · filed 2022-08-25 | |
| 2021-12-31 | 5.00B shares 20-F · filed 2023-03-30 | |
| 2021-06-30 | 5.00B shares 6-K · filed 2021-08-26 | |
| 2020-12-31 | 1.00B shares 20-F · filed 2022-03-24 | |
| 2020-06-30 | 500.00M shares 6-K · filed 2020-08-27 | |
| 2019-12-31 | 500.00M shares 20-F · filed 2021-03-25 | |
| 2018-12-31 | 500.00M shares 6-K · filed 2020-06-01 |